
Auteur J. KLIMAS
|
Documents disponibles écrits par cet auteur (8)

J. KLIMAS ; W. Y. MOK ; S. LAKE ; M. E. SOCIAS ; K. DEBECK ; K. HAYASHI ; E. WOOD ; M. J. MILLOY | 2022
Dans Journal of Substance Use (Vol.27, n°3, June 2022) Article : PériodiqueBackground: While preliminary evidence has begun to document intentional use of one substance to reduce the use of another, the phenomenon of drug substitution among people who use illicit opioids remains understudied. Therefore, we sought to es[...]Nouveauté
J. KLIMAS ; H. TOBIN ; M. EGAN ; B. TOMAS ; G. BURY | 2016
Dans International Journal of Drug Policy (Vol.38, December 2016) Article : PériodiqueHeroin use continues to drive opioid-related overdoses and mortality globally (Degenhardt & Hall, 2012). Not-as-prescribed use of prescription opioids increases the number of victims of this epidemic (Logan, Liu, Paulozzi, Zhang, & Jones, 2013).[...]
J. KLIMAS ; C. A. FIELD ; W. CULLEN ; C. S. M. O'GORMAN ; L. G. GLYNN ; E. KEENAN ; J. SAUNDERS ; G. BURY ; C. DUNNE | 2011
Dans Cochrane Database of Systematic Reviews (n°8, 2011) Article : PériodiqueThis is the protocol for a review and there is no abstract. The objectives are as follows: To determine the effectiveness of psychosocial interventions targeting problem alcohol use versus other treatments in illicit drug users.
J. KLIMAS ; C. A. FIELD ; W. CULLEN ; C. S. M. O'GORMAN ; L. G. GLYNN ; E. KEENAN ; J. SAUNDERS ; G. BURY ; C. DUNNE | 2012
Dans Cochrane Database of Systematic Reviews (n°11, 2012) Article : PériodiqueBACKGROUND: Problem alcohol use is common among illicit drug users and is associated with adverse health outcomes. It is also an important factor in poor prognosis among drug users with hepatitis C virus (HCV) as it impacts on progression to hep[...]
J. KLIMAS ; H. TOBIN ; C. A. FIELD ; C. S. M. O'GORMAN ; L. G. GLYNN ; E. KEENAN ; J. SAUNDERS ; G. BURY ; C. DUNNE ; W. CULLEN | 2014
Dans Cochrane Database of Systematic Reviews (n°12, 2014) Article : PériodiqueBACKGROUND: Problem alcohol use is common among illicit drug users and is associated with adverse health outcomes. It is also an important factor contributing to a poor prognosis among drug users with hepatitis C virus (HCV) as it impacts on pro[...]
J. KLIMAS ; C. FAIRGRIEVE ; H. TOBIN ; C. A. FIELD ; C. S. O'GORMAN ; L. G. GLYNN ; E. KEENAN ; J. SAUNDERS ; G. BURY ; C. DUNNE ; W. CULLEN | 2018
Dans Cochrane Database of Systematic Reviews (n°12, 2018) Article : PériodiqueReview question: We wanted to see whether talking therapies reduce drinking in adult users of illicit drugs (mainly opioids and stimulants). We also wanted to find out whether one type of therapy is more effective than another. Background: Drin[...]
M. SINGH ; D. KEER ; J. KLIMAS ; E. WOOD ; D. WERB | 2016
Dans Addiction (Vol.111, n°8, August 2016) Article : PériodiqueAims: To assess the efficacy of topiramate in treating cocaine use disorder (i.e. retention, efficacy, safety and craving reduction) through a systematic review and meta-analysis. Methods: We searched six scientific databases from inception to[...]
C. RONSLEY ; S. NOLAN ; R. KNIGHT ; K. HAYASHI ; J. KLIMAS ; A. WALLEY ; E. WOOD ; N. FAIRBAIRN | 2020
Dans PLOS ONE (Vol.15, n°6, June 2020) Article : PériodiqueAims: Stimulant use disorder contributes to a substantial worldwide burden of disease, although evidence-based treatment options are limited. This systematic review of reviews aims to: (i) synthesize the available evidence on both psychosocial a[...]